drugset / Trial / NCT00562549

Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension

NCT00562549 ↗

Phase 2 Completed 26 enrolled Retension Pharmaceuticals. Inc.
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose is to determine the effective dosage and to study the effects of this dosage taken for 12 days on systolic and diastolic blood pressure in patients with hypertension.

Timeline

Start
2007-07
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject SLx-2101 Unknown 5 mg Oral
Subject SLx-2101 Unknown 10 mg Oral
Subject SLx-2101 Unknown 20 mg Oral

Indications